華夏視聽教育(1981.HK)漲超12%再創上市新高 市值突破90億港元
格隆匯7月21日丨剛於7月16日上市的華夏視聽教育(1981.HK)今日繼續大漲創上市新高價5.76港元,現漲12.57%報5.73港元,暫成交7968萬港元,最新總市值91.8億港元。現價相較於IPO發行價3.1港元上漲84%。業內人士稱,華夏視聽教育開創了“高等教育+產業”打包共同上市的先河,對應形成了“藝術教育+影視傳媒”雙輪驅動的業務模式。其傳媒及藝術專業高等教育業務、影視製作業務等兩大基石業務彼此緊密合作,顯示出強大的協同效應。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.